Cypher stent safe despite clotting cases, says FDA
This article was originally published in Clinica
Executive Summary
The US FDA has clarified its position on the Cypher drug-coated stent made by Johnson & Johnson's Cordis, saying it believes the device to be "safe and effective when used according to the labelling". Concerns were sparked in October when it drew attention to reports of thrombosis following implantation (see Clinica No 1082, p 19).